Skip to main content
Eric Donnenfeld, MD, Ophthalmology, Garden City, NY

EricDDonnenfeldMD

Ophthalmology Garden City, NY

Cornea & External Disease, Refractive Surgery

Clinical professor of ophthalmology NYU

Dr. Donnenfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Donnenfeld's full profile

Already have an account?

  • Office

    711 Stewart Ave
    Garden City, NY 11530
    Phone+1 516-500-4200
    Fax+1 516-766-3714

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1984 - 1985
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 1981 - 1984
  • Newton-Wellesley Hospital
    Newton-Wellesley HospitalInternship, Internal Medicine, 1980 - 1981
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1980

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1981 - 2026
  • CT State Medical License
    CT State Medical License 1999 - 2025
  • PA State Medical License
    PA State Medical License 1984 - 1986
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
  • Top MD Consumers Checkbook
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Navigating Through the Noise
    Navigating Through the NoiseJuly 15th, 2022
  • Oculis Announces First Patient Enrolled in Phase3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery
    Oculis Announces First Patient Enrolled in Phase3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract SurgeryJune 27th, 2022
  • New Dry Eye Treatment Technology to Address MGD Launches
    New Dry Eye Treatment Technology to Address MGD LaunchesApril 13th, 2022
  • Join now to see all

Professional Memberships